Discovery of novel thiourea derivatives as potent and selective β3-adrenergic receptor agonists

被引:13
作者
Maruyama, Tatsuya [1 ]
Seki, Norio [1 ]
Onda, Kenichi [1 ]
Suzuki, Takayuki [1 ]
Kawazoe, Souichirou [1 ]
Hayakawa, Masahiko [1 ]
Matsui, Tetsuo [1 ]
Takasu, Toshiyuki [1 ]
Ohta, Mitsuaki [1 ]
机构
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
关键词
beta 3-Adrenergic receptor; Agonist; Thiourea; Phenoxypropanolamine; Diabetes; BETA(3) ADRENERGIC-RECEPTOR; HUMAN DETRUSOR MUSCLE; BETA(3)-ADRENOCEPTOR AGONISTS; OBESITY; ADRENOCEPTOR; EXPRESSION; SUBTYPES; DRUGS;
D O I
10.1016/j.bmc.2009.06.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes, we prepared a novel series of phenoxypropanolamine derivatives containing the thiourea moiety and evaluated their biological activities at human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 4-nitrophenylthiourea (18i) and 3-methoxyphenylthiourea (18k) derivatives were found to exhibit potent agonistic activity at the b3-AR, with EC(50) values of 0.10 and 0.16 mu M, respectively, and no agonistic activity for either the beta 1-or beta 2-AR. In addition, they showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5510 / 5519
页数:10
相关论文
共 50 条
  • [11] Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β3-Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5
    Hattori, Kouji
    Toda, Susumu
    Imanishi, Masashi
    Itou, Shinji
    Nakajima, Yutaka
    Washizuka, Kenichi
    Araki, Takanobu
    Hamashima, Hitoshi
    Tomishima, Yasuyo
    Sakurai, Minoru
    Matsui, Shigeo
    Imamura, Emiko
    Ueshima, Koji
    Yamamoto, Takao
    Yamamoto, Nobuhiro
    Ishikawa, Hirofumi
    Nakano, Keiko
    Unami, Naoko
    Hamada, Kaori
    Matsumura, Yasuhiro
    Takamura, Fujiko
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 3063 - 3072
  • [12] Recent developments in the design of orally bioavailable β3-adrenergic receptor agonists
    Sawa, M
    Harada, H
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (01) : 25 - 37
  • [13] Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids
    Shearer, Barry G.
    Chao, Esther Y.
    Uehling, David E.
    Deaton, David N.
    Cowan, Conrad
    Sherman, Bryan W.
    Milliken, Tula
    Faison, Walter
    Brown, Kathleen
    Adkison, Kimberly K.
    Lee, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4670 - 4677
  • [14] Discovery of novel prostacyclin mimetics with highly potent and selective IP receptor agonists
    Hattori, Kouji
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2006, 64 (09) : 923 - 933
  • [15] The use of β3-adrenergic receptor agonists in the treatment of heart failure
    Rasmussen, Helge H.
    Figtree, Gemma A.
    Krum, Henry
    Bundgaard, Henning
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 955 - 962
  • [16] Discovery of Novel Selective Human β3 Adrenergic Receptor Agonists as Potential Overactive Bladder (OAB) Therapies
    Imanishi, Masashi
    Hattori, Kouji
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2011, 69 (12) : 1402 - 1410
  • [17] Might β3-adrenergic receptor agonists be useful in disorders of glucose homeostasis?
    Flier, Jeffrey S.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) : 2180 - 2182
  • [18] Tryptamine-based human β3-adrenergic receptor agonists.: Part 2:: SAR of the methylene derivatives
    Sawa, M
    Tateishi, H
    Mizuno, K
    Harada, H
    Oue, M
    Tsujiuchi, H
    Furutani, Y
    Kato, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 5963 - 5966
  • [19] Discovery of phenyl acetamides as potent and selective GPR119 agonists
    Zhu, Cheng
    Wang, Liping
    Zhu, Yuping
    Guo, Zack Zhiqiang
    Liu, Ping
    Hu, Zhiyong
    Szewczyk, Jason W.
    Kang, Ling
    Chicchi, Gary
    Ehrhardt, Anka
    Woods, Andrea
    Seo, Toru
    Woods, Morgan
    van Heek, Margaret
    Dingley, Karen H.
    Pang, Jianmei
    Salituro, Gino M.
    Powell, Joyce
    Terebetski, Jenna L.
    Hornak, Viktor
    Campeau, Louis-Charles
    Orr, Robert K.
    Ujjainwalla, Feroze
    Miller, Michael
    Stamford, Andrew
    Wood, Harold B.
    Kowalski, Timothy
    Nargund, Ravi P.
    Edmondson, Scott D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (05) : 1124 - 1128
  • [20] Development and Characterization of a Highly Selective Turn-On Fluorescent Ligand for β3-Adrenergic Receptor
    Li, Wenhua
    Ma, Zhao
    Du, Lupei
    Li, Minyong
    ANALYTICAL CHEMISTRY, 2023, 95 (05) : 2848 - 2856